InvestorsHub Logo
Followers 129
Posts 22492
Boards Moderated 0
Alias Born 10/03/2016

Re: None

Monday, 09/25/2017 2:16:44 PM

Monday, September 25, 2017 2:16:44 PM

Post# of 94133
About Plandai Biotechnology SA
Through its wholly owned subsidiary Plandai Biotechnology SA (OTC PINK:PLPL), the Company has the exclusive worldwide license to develop Phytofare® extracts from live plant materials including Phytofare® catechin complex, a highly bioavailable, and clinically proven antioxidant complex produced from live green tea leaves. Phytofare® can deliver a therapeutic level of catechins, which function as powerful antioxidants, to the system where they remain active for over 24 hours.


http://www.nasdaq.com/press-release/protext-pharma-ceo-discusses-south-africa-cannabis-license-20170713-00751

Oh NOOOOOO! The ONLY real South African based company here is PLPL?

No NON South African company stock can rise on licence issuance? Only SOUTH AFRICAN based company's STOCK PRICE can rise? (i.e. PLPL, not TXTM)

"...We believe we're uniquely positioned to be granted this license having developed an expertise in the extraction of phytonutrients from live plants, as well as having a home base and corporate presence in South Africa (PLPL) for some years..."

http://www.nasdaq.com/press-release/protext-pharma-announces-south-africas-reclassification-of-cannabis-as-a-schedule-4-substance-20170920-00501

We got screwed?

What are your thoughts about this?